about
Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonismChromosome 6-linked autosomal recessive early-onset Parkinsonism: linkage in European and Algerian families, extension of the clinical spectrum, and evidence of a small homozygous deletion in one family. The French Parkinson's Disease Genetics StudyAutosomal recessive early onset parkinsonism is linked to three loci: PARK2, PARK6, and PARK7A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's DiseaseGenome-wide scan linkage analysis for Parkinson's disease: the European genetic study of Parkinson's diseaseAssociation between early-onset Parkinson's disease and mutations in the parkin geneDonepezil in the treatment of progressive supranuclear palsy.Novel parkin mutations detected in patients with early-onset Parkinson's disease.High prevalence of extrapyramidal signs and symptoms in a group of Italian dental techniciansNew, selective catechol-O-methyltransferase inhibitors as therapeutic agents in Parkinson's disease.Attentional functions in multiple system atrophy and Parkinson's diseaseThe Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease.PARK6 is a common cause of familial parkinsonism.How much phenotypic variation can be attributed to parkin genotype?Hedonistic homeostatic dysregulation in Parkinson's disease: a short screening questionnaire.Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease.Reversible Pisa syndrome associated to subdural haematoma: case-reportATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.Three parkin gene mutations in a sibship with autosomal recessive early onset parkinsonism.The European Multiple System Atrophy-Study Group (EMSA-SG).The natural history of multiple system atrophy: a prospective European cohort studyMotor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study.Estimate of parkinsonism prevalence through drug prescription histories in the Province of Rome, Italy.Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects.Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms.Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.Mortality in a population-based cohort of patients treated with antiparkinsonian drugs.Multicenter trial of L-Deprenyl in Parkinson disease.Buspirone in levodopa-induced dyskinesias.Donepezil in the treatment of hallucinations and delusions in Parkinson's disease.Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: an open-label, long-term study.Risperidone for hallucinations in levodopa-treated Parkinson's disease patients.Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease.Risperidone in levodopa induced dyskinesiae.Frontal lobe dysfunction in essential tremor: a preliminary study.Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease.Excessive daytime sleepiness in de novo and treated Parkinson's disease.Mirtazapine in L-dopa-induced dyskinesias.Clinical subtypes in Parkinson's disease: the impact of MAPT haplotypes.
P50
Q24321359-C32B9A1F-C75A-4A2B-A10C-E1C91A332346Q24539105-5901BED5-9600-4E98-8BA6-D85DF2EBA994Q28205082-92D7101F-D517-40E5-B3D3-F1E16C31610CQ28371129-58CD89CE-7CC7-4BDB-B986-0FDBE4C02A12Q28764371-A4DE5773-E790-4485-AF5D-23F13410F60EQ29615733-11A9E887-E529-4B72-9847-D796597DE3D6Q32066353-F63B875E-D0FA-492A-83CB-103B414A055EQ33209648-06DA0276-B571-44A2-B034-3143AD56793DQ33293612-BB3A314D-CA11-4E14-A05E-5AA2D44DAB50Q33537438-19E3F563-7663-433B-8681-DFC49DAF825AQ33735208-F2448F70-6BEC-43D7-B29A-62979CA5C588Q33871506-220DC20D-BD79-4158-AA87-3C804BD6B9C4Q34172948-E86D14E0-0F4B-48DA-9687-47A91FE1F618Q34218728-5C9F1C46-9B3C-4E8C-BEC2-FC2A2460B9B5Q34274448-92FBD798-B917-407B-836D-0678DD85A8F1Q34351580-75628971-A908-4F03-9373-5CC66C5A26F5Q34538628-3A9DE9B4-2FFC-4B80-8C8B-0B338425F699Q34626200-08C1D5A7-7B1D-4AFB-AC26-73EDDFE320E5Q35447263-88C9705F-429C-4B68-9CD5-97C5705C6B78Q35572397-6FC93FA8-430B-402D-AFB3-C1F15904C88FQ36210318-D316CC67-4706-4603-A21B-017A75E5D7BEQ36637012-AD6097A6-38C5-4802-BF03-DC9E564C0E85Q37342303-505ED468-A69E-4E6A-AEB4-B62086E25183Q39372493-AC3B52AE-6FB4-4300-9561-C7BBA7C4A24EQ39412774-69D6677A-4F5E-41DB-A2FD-57A664B0ADECQ39552636-6F1A62FE-9BAB-48C6-B77F-9BBF5300CB2CQ39830590-D54E459B-B4BC-4ADB-AEE4-6609976A52A1Q41712739-5D74A965-095E-4E1C-A5D7-66960C98A412Q41837808-8488F947-1AF5-4687-85F3-FA7F8B6A2245Q42285208-D7FD6118-4738-4DD9-8D51-CB20447470C8Q42523530-30C43B75-F239-486A-AEB5-875AD365E2F2Q42548286-8586E399-D463-46EC-90F9-42DAD819848EQ42569474-7DFF388A-7D0D-42D7-AA25-A49B012806C1Q42675021-F5A2BE02-701D-4179-A245-19C21134DFF8Q42726023-80C12CA9-F1CD-452F-9908-5287828DCD21Q43661631-BD9B6703-A06A-4764-9011-69787FE26A17Q43786637-6E4B3521-35B6-4ABB-A293-6D342535E472Q44165259-71B708E6-4507-4613-B0BF-CA2BDD626FECQ44536093-D439AF61-4472-42C8-A3D4-82C7B48A94FBQ45009668-18D92FDB-2871-4BE7-841D-1012F20FA031
P50
description
onderzoeker
@nl
name
Giuseppe Meco
@ast
Giuseppe Meco
@en
Giuseppe Meco
@es
Giuseppe Meco
@nl
type
label
Giuseppe Meco
@ast
Giuseppe Meco
@en
Giuseppe Meco
@es
Giuseppe Meco
@nl
altLabel
G Meco
@en
Meco G
@en
prefLabel
Giuseppe Meco
@ast
Giuseppe Meco
@en
Giuseppe Meco
@es
Giuseppe Meco
@nl